fluorodeoxyglucose f18 has been researched along with Biliary Tract Cancer in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 16 (61.54) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, S; Kubo, M | 1 |
| Akita, H; Doki, Y; Eguchi, H; Gotoh, K; Iwagami, Y; Kato, H; Kobayashi, S; Kubo, M; Noda, T; Shimosegawa, E; Takayama, H; Tomimaru, Y; Yamada, D | 1 |
| Choyke, PL | 1 |
| Bariani, GM; Braghiroli, MI; Buchpiguel, CA; Duarte, PS; Hoff, PM; Morita, TO; Mota, JM; Nebuloni, D; Riechelmann, RP | 1 |
| Barriuso, J; Chander, A; Hubner, RA; Lamarca, A; Manoharan, P; McNamara, MG; ÓReilly, D; Valle, JW | 1 |
| Fukushi, M; Inoue, K; Kishimoto, S; Minamimoto, R; Mitsumoto, T; Sunaoka, F | 1 |
| Choi, DW; Choi, JY; Choi, MK; Choi, SH; Heo, JS; Lee, J; Lee, JK; Lee, KH; Lee, KT; Lim, HY; Park, JO; Park, YS | 1 |
| Galluzzo, A; Hayano, K; Sahani, DV; Zhu, AX | 1 |
| Matsusaka, Y; Murakami, K | 1 |
| Bang, YJ; Cho, KM; Han, SW; Im, SA; Kim, TY; Lee, KH; Oh, DY | 1 |
| Agrawal, K; Gupta, R; Kaman, L; Kochhar, R; Mittal, BR; Singh, R; Singh, V; Verma, GR; Vineeth Kumar, PM | 1 |
| Kaneta, T; Takahashi, S; Takanami, K; Yamada, S | 1 |
| Asakura, K; Furukawa, H; Ikuma, H; Uesaka, K | 1 |
| Fujii, H; Fukuda, H; Kanegae, K; Kaneta, T; Kitajima, K; Kubota, K; Murakami, K; Nakajima, K; Nakamoto, Y; Suga, T; Tamaki, N; Tateishi, U | 1 |
| Lam, WW; Osmany, S | 1 |
| Abrams, TA; Allen, JN; Bhargava, P; Blaszkowsky, LS; Chan, JA; Clark, JW; Enzinger, PC; Fuchs, CS; Horgan, K; Jain, SR; Kambadakone, AR; Kwak, EL; Meyerhardt, JA; Muzikansky, A; Ryan, DP; Sahani, DV; Sheehan, S; Stuart, K; Zheng, H; Zhu, AX | 1 |
| Furuse, J | 1 |
| Doki, Y; Eguchi, H; Hatazawa, J; Hoshino, H; Kim, T; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Shimosegawa, E; Takeda, Y; Tanemura, M; Wada, H | 1 |
| Beer, AJ; Buck, AK; Eckel, F; Herrmann, K | 1 |
| Bang, YJ; Chie, EK; Ha, SW; Han, SW; Im, SA; Jang, JY; Kim, SW; Kim, TY; Lee, YG; Oh, DY | 1 |
| Bonomo, L; Castaldi, P; De Gaetano, AM; Filograna, L; Gatto, AM; Giordano, A; Rufini, V | 1 |
| Andersson, R; Ansari, D; Keussen, I | 1 |
| Ajiki, T; Fukumoto, T; Kotani, J; Ku, Y; Matsumoto, I; Nakao, A; Otsubo, I; Sawa, H; Shinzeki, M; Toyama, H; Ueno, K; Yamada, I; Yoshida, Y | 1 |
| Annovazzi, A; Dierckx, R; Maenhout, A; Peeters, M; Signore, A; Van De Wiele, C | 1 |
| Akamoto, S; Izuishi, K; Maeta, H; Nishiyama, Y; Okano, K; Wakabayashi, H; Yachida, S | 1 |
| Kimura, N; Miki, A; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Wakabayashi, H; Yamamoto, Y | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Biliary Tract Cancer
| Article | Year |
|---|---|
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
Topics: Adenocarcinoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Positron emission tomography in malignancies of the liver, pancreas and biliary tract - indications and potential pitfalls.
Topics: Biliary Tract Neoplasms; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract.
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Pancreatic Neoplasms; Tomography, Emission-Computed | 2003 |
4 trial(s) available for fluorodeoxyglucose f18 and Biliary Tract Cancer
| Article | Year |
|---|---|
Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer.
Topics: Adult; Aged, 80 and over; Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis | 2018 |
Prognostic and predictive value of metabolic tumor volume on (18)F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Deoxycytidine; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gemcitabine; Glycolysis; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Quinazolines; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Measuring treatment response to systemic therapy and predicting outcome in biliary tract cancer: comparing tumor size, volume, density, and metabolism.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biliary Tract Neoplasms; Contrast Media; Deoxycytidine; Disease Progression; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biliary Tract Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Time Factors; Treatment Outcome | 2010 |
18 other study(ies) available for fluorodeoxyglucose f18 and Biliary Tract Cancer
| Article | Year |
|---|---|
ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis.
Topics: Biliary Tract Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Prognosis | 2022 |
Preoperative FDG-Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers.
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
PET of Fibroblast-Activation Protein for Cancer Staging: What We Know and What We Need to Learn.
Topics: Biliary Tract Neoplasms; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
The clinical utility of phase-based respiratory gated PET imaging based on visual feedback with a head-mounted display system.
Topics: Aged; Biliary Tract Neoplasms; Equipment Design; Feedback, Sensory; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Retrospective Studies; Sensitivity and Specificity; User-Computer Interface | 2019 |
[Imaging diagnosis of biliary tract cancer on PET].
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence | 2015 |
Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.
Topics: Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolism; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Retrospective Studies | 2015 |
FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary Lesions.
Topics: Adult; Aged; Biliary Tract Neoplasms; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
F-18 FDG PET/CT scan in biliary cystadenocarcinoma.
Topics: Aged; Biliary Tract Neoplasms; Cystadenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.
Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Sex Factors | 2009 |
Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter study.
Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Biliary non-Hodgkin lymphoma detected by F-18 FDG PET/CT.
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Targeted therapy for biliary-tract cancer.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biliary Tract Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Time Factors; Treatment Outcome | 2010 |
Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2011 |
Pancreatic and hepatobiliary cancers.
Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.
Topics: Adult; Aged; Biliary Tract Neoplasms; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2012 |
Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture.
Topics: Aged; Bile; Biliary Tract Neoplasms; Cholestasis; Cytological Techniques; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Comparison of early and delayed FDG PET for evaluation of biliary stricture.
Topics: Aged; Aged, 80 and over; Bile Duct Diseases; Biliary Tract Neoplasms; Constriction, Pathologic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2007 |